Avid Bioservices, Inc.
CDMO · NASDAQ
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Market Cap | $635,826 | $664,391 | $484,474 | $428,683 |
| - Cash | $33,415 | $33,381 | $38,106 | $30,708 |
| + Debt | $205,526 | $207,434 | $207,834 | $196,326 |
| Enterprise Value | $807,937 | $838,444 | $654,202 | $594,301 |
| Revenue | $33,482 | $40,173 | $42,975 | $33,815 |
| % Growth | -16.7% | -6.5% | 27.1% | – |
| Gross Profit | -$2,045 | $5,713 | $5,500 | $2,383 |
| % Margin | -6.1% | 14.2% | 12.8% | 7% |
| EBITDA | -$10,158 | -$256 | -$561 | -$3,256 |
| % Margin | -30.3% | -0.6% | -1.3% | -9.6% |
| Net Income | -$17,406 | -$5,534 | -$123,104 | -$6,006 |
| % Margin | -52% | -13.8% | -286.5% | -17.8% |
| EPS Diluted | -0.27 | -0.087 | -1.94 | -0.095 |
| % Growth | -210.3% | 95.5% | -1,944.3% | – |
| Operating Cash Flow | -$4,878 | -$3,680 | $1,257 | $3,687 |
| Capital Expenditures | $15,263 | -$1,311 | -$5,693 | -$4,488 |
| Free Cash Flow | $10,385 | -$4,991 | -$4,436 | -$801 |